tiprankstipranks
AC Immune’s Promising Trial Results for Parkinson’s Therapy
PremiumCompany AnnouncementsAC Immune’s Promising Trial Results for Parkinson’s Therapy
2M ago
AC Immune SA Reports Profitable Q3 2024 Results
Premium
Company Announcements
AC Immune SA Reports Profitable Q3 2024 Results
2M ago
AC Immune reports Q3 EPS CHF 0.05 vs (CHF 0.18) last year
Premium
The Fly
AC Immune reports Q3 EPS CHF 0.05 vs (CHF 0.18) last year
2M ago
FDA grants AC Immune’s PI-2620 Tau-PET diagnostic fast track designations
PremiumThe FlyFDA grants AC Immune’s PI-2620 Tau-PET diagnostic fast track designations
5M ago
AC Immune SA Announces $80M Open Market Sales Plan
Premium
Company Announcements
AC Immune SA Announces $80M Open Market Sales Plan
5M ago
AC Immune SA Strikes Licensing Deal with Takeda
Premium
Company Announcements
AC Immune SA Strikes Licensing Deal with Takeda
6M ago
AC Immune’s ACI-35.030 granted FDA Fast Track Designation
PremiumThe FlyAC Immune’s ACI-35.030 granted FDA Fast Track Designation
6M ago
AC Immune announces three oral presentations at AAIC 2024
Premium
The Fly
AC Immune announces three oral presentations at AAIC 2024
6M ago
AC Immune SA Announces Major Takeda Partnership
Premium
Company Announcements
AC Immune SA Announces Major Takeda Partnership
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100